1) Validated testing methods for the assessment of increased intestinal permeability in clinical practice,
2) Clinically relevant and suggestive markers to indicate a compromised intestinal barrier,
3) Treatment objectives for increased intestinal permeability in clinical practice.
During the second webinar, a focus will be placed on the assessment and identification of increased intestinal permeability in clinical practice. Brad will share the assessment methods that have been validated and are known to have the highest degree of accuracy in clinical practice. Furthermore, a variety of suggestive markers that clinicians can use in their clinical practice to identify patients with impaired intestinal barrier will be explored. Finally, the four main treatment objectives that clinicians may want to implement in managing patients with increased intestinal permeability will be discussed.
Brad Leech is an internationally recognised Clinical Nutritionist and Ayurvedic Herbalist. After entering the integrative medicine profession in 2008, Brad has taught and developed subjects at leading academic institutions in Integrative Gastroenterology, Naturopathic Medicine, Nutritional and Dietetic Medicine and Public Health Research. As Clinical Science Lead in integrated and functional medicine at Microba, his expertise in integrative gastrointestinal healthcare enables him to translate the latest science on the gut microbiome into practical clinical application. Brad is in the final stages of completing his PhD at the Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney. His research involves developing the IP Guidelines, an evidence-based clinical practice guideline for managing increased intestinal permeability. His previous research has focused on autoimmune disease management, health outcomes associated with food-based probiotics and integrative healthcare management.